Copperwynd Financial, LLC Abbott Laboratories Transaction History

Copperwynd Financial, LLC

$330 Million
Q3 2024

A detailed history of Copperwynd Financial, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Copperwynd Financial, LLC holds 9,373 shares of ABT stock, worth $1.07 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

9,373

Previous 8,620 8.74%

Holding current value

$1.07 Million

Previous $895,000 19.33%

% of portfolio

0.32%

Previous 0.28%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$100.07 - $118.13 $75,352 - $88,951	753 Added 8.74%	9,373 $1.07 Million
Q2 2024 Aug 15, 2024	BUY	$100.73 - $112.44 $229,865 - $256,588	2,282 Added 36.01%	8,620 $895,000
Q1 2024 Apr 30, 2024	BUY	$109.52 - $120.96 $72,502 - $80,075	662 Added 11.66%	6,338 $720,000
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $40,765 - $49,900	452 Added 8.65%	5,676 $624,000
Q3 2023 Nov 07, 2023	BUY	$95.53 - $114.62 $16,335 - $19,600	171 Added 3.38%	5,224 $505,000
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $3,224 - $3,593	32 Added 0.64%	5,053 $550,000
Q1 2023 Apr 28, 2023	BUY	$96.86 - $114.01 $27,992 - $32,948	289 Added 6.11%	5,021 $508,000
Q4 2022 Feb 02, 2023	SELL	$95.06 - $111.52 $54,659 - $64,124	-575 Reduced 10.83%	4,732 $519,000
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $12,095 - $14,003	-125 Reduced 2.3%	5,307 $514,000
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $44,400 - $53,665	-435 Reduced 7.41%	5,432 $590,000
Q1 2022 Apr 21, 2022	SELL	$114.02 - $139.04 $50,054 - $61,038	-439 Reduced 6.96%	5,867 $694,000
Q4 2021 Feb 04, 2022	BUY	$115.53 - $141.46 $77,289 - $94,636	669 Added 11.87%	6,306 $888,000
Q3 2021 Nov 03, 2021	BUY	$116.66 - $129.06 $70,112 - $77,565	601 Added 11.93%	5,637 $666,000
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $70,667 - $83,186	668 Added 15.29%	5,036 $584,000
Q1 2021 May 06, 2021	BUY	$108.84 - $128.23 $41,359 - $48,727	380 Added 9.53%	4,368 $523,000
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $62,265 - $67,851	593 Added 17.47%	3,988 $437,000
Q3 2020 Nov 05, 2020	BUY	$91.64 - $111.29 $83,758 - $101,719	914 Added 36.84%	3,395 $369,000
Q2 2020 Aug 07, 2020	BUY	$76.57 - $98.0 $189,970 - $243,138	2,481 New	2,481 $227,000
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $1.86 Million - $2.25 Million	-28,148 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$65.56 - $74.27 $1.85 Million - $2.09 Million	28,148 New	28,148 $2.04 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copperwynd Financial, LLC with notifications on news.

Account

Copperwynd Financial, LLC Abbott Laboratories Transaction History